Sun, 29-May-2022

Oncology

Gilead Sciences and Tango Therapeutics to Expand Str...

Gilead Sciences, Inc. and Tango Therapeutics announced an expanded strategic collaboration focused on the discovery, development and commercialization of innovative targeted immune evasion therapies for patien... August 18, 2020 6:55 am By Neha Mule

Pharma and Biotech Companies Performing Strategic Ac...

Since past few years, global healthcare is consistently working on cancer treatments. Various common and rare cancer cases are being detected and this disease is killing patients due to unavailability of effic... August 14, 2020 2:37 pm By Neha Mule

Burning Rock and CStone Pharmaceuticals Announce Col...

On June 29, 2020, Burning Rock Biotech Limited announced a strategic partnership with CStone Pharmaceuticals to co-develop and commercialize companion diagnostics (CDx) for pralsetinib, an investigational trea... June 29, 2020 6:24 am By Neha Mule

FDA Approves Deciphera Pharmaceuticals’ Drug for F...

Deciphera Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved QINLOCK (ripretinib) for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST)... May 19, 2020 6:02 am By Neha Mule

LYNPARZA Approved by FDA as First-Line Maintenance T...

AstraZeneca and Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved LYNPARZA in combination with bevacizumab as a first-line mainte... May 11, 2020 6:24 am By Neha Mule

The Center for Cancer and Blood Disorders Joins the ...

American Oncology Network, LLC (AON) announced that The Center for Cancer and Blood Disorders (CCBD), a community oncology and hematology practice serving Bethesda and Germantown, Maryland, has joined AON, e... May 5, 2020 7:04 am By Neha Mule

Denovo Biopharma to Acquire Tocagen’s Entire Repli...

Denovo Biopharma LLC announced it is acquiring Tocagen’s retroviral replicating vector platform (RRV) in its entirety, including its investigational gene therapy and drug regimen for oncology: Toca 511 and T... April 29, 2020 9:01 am By Neha Mule

1 2 3 4

Related News